US Patent

US10888534 — Storage stable ready-to-use norepinephrine aqueous solutions in flexible plastic bags

Formulation · Assigned to Inforlife SA · Expires 2039-04-26 · 13y remaining

Vulnerability score 50/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a sterile, sulfite-free aqueous norepinephrine solution packaged in a flexible plastic container that remains stable for 12-24 months at room temperature.

USPTO Abstract

A sterile, sulfite-free aqueous norepinephrine solution comprising up to about 0.2 mg/ml of norepinephrine concentration (as free base), a tonicity adjusting agent, at a pH where the norepinephrine is soluble which is packaged in a flexible plastic container, characterized by being storage stable for from about 12 months to about 24 months at room temperature of about 25° C.

Drugs covered by this patent

Patent Metadata

Patent number
US10888534
Jurisdiction
US
Classification
Formulation
Expires
2039-04-26
Drug substance claim
No
Drug product claim
Yes
Assignee
Inforlife SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.